CGP 78608 hydrochloride

• Supplier: Tocris Bioscience
• Catalog: 5472
• Prices: $199.00, $825.00
• Sizes: 10 mg, 50 mg
• Function Type: Antagonist
• Cas Number: 1135278-54-4
• Chemical Name: [(1S)-1-[[(7-Bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonicacidhydrochloride
• Formula: C11H13BrN3O5P.HCl
• Molecular Weight: 414.58
• Purity: >98 %
• Description: Potent and selective NMDA antagonist that acts through the glycine site (IC 50 = 5 nM). Displays > 500-fold selectivity over kainate and AMPA receptors (IC 50 values are 2.7 and 3 μ M respectively). Anticonvulsant in vivo following systemic administration. Also available as part of the NMDA Receptor - Glycine Site Tocriset™ .

Product References

Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- - Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4-

John CS, Vilner BJ, Bowen WD. J Med Chem. 1994 Jun 10;37(12):1737-9.

Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, - Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency,

Whittemore ER, Ilyin VI, Woodward RM. J Pharmacol Exp Ther. 1997 Jul;282(1):326-38.

N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and - N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and

Auberson YP, Acklin P, Bischoff S, Moretti R, Ofner S, Schmutz M, Veenstra SJ. Bioorg Med Chem Lett. 1999 Jan 18;9(2):249-54.

Synthesis, radiolabelling and biological characterization of - Synthesis, radiolabelling and biological characterization of

Ametamey SM, Kokic M, Carrey-Remy N, Blauenstein P, Willmann M, Bischoff S, Schmutz M, Schubiger PA, Auberson YP. Bioorg Med Chem Lett. 2000 Jan 3;10(1):75-8.